Using data science to identify aggressive cancer types and predict survival in head and neck cancer without HPV.
Data science approaches to classify aggressive tissue phenotypes and predict disease-free survival in HPV-negative head and neck squamous cell carcinoma (HNSCC)
This study is looking at a type of throat and neck cancer that isn't caused by HPV, and it aims to use new data techniques to better understand how different tissue types affect survival, which could help doctors make more personalized treatment choices for patients.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11114716 on NIH RePORTER |
What this research studies
This research focuses on head and neck squamous cell carcinoma (HNSCC) that is negative for human papillomavirus (HPV). It aims to use advanced data science techniques to classify aggressive tissue types and understand their impact on patient survival. By analyzing genetic differences and histopathologic factors, the study seeks to improve the accuracy of prognostic factors beyond traditional staging methods. This could lead to better treatment decisions tailored to individual patient needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with HPV-negative head and neck squamous cell carcinoma.
Not a fit: Patients with HPV-positive head and neck cancers or those with other unrelated cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate predictions of disease outcomes and personalized treatment strategies for patients with HPV-negative head and neck cancer.
How similar studies have performed: Other research has shown promise in using data science and molecular analysis to improve cancer prognostics, indicating that this approach could be effective.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Liu, Yingci — Rutgers Biomedical and Health Sciences
- Study coordinator: Liu, Yingci
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.